Skip to main content

Table 1 Summary of IHC analysis of REGγ expression in multiple human cancer tissue

From: REGγ is associated with multiple oncogenic pathways in human cancers

    REGγ Level    p value
Cancer type Sample
Amount
     
   - + ++/+++ -v.s + -v.s
++/+++
lung cancer 92 8 (8.7%) 34 (37.0%) 50 (54.3%) 3.70E-04 i.61E-13
colon cancer 48 2 (4.2%) 16 (33.3%) 30 (62.5%) 1.74E-04 8.63E-06
thyroid cancer 49 2 (4.1%) 16 (32.7%) 31(63.3%) 1.44E-01 7.09E-02
liver cancer 206 5 (2.4%) 36 (17.5%) 165 (80.1%) 5.68E-03 8.44E-07
total 395 17 (4.3%) 102
(25.8%)
276 (69.9%)   
  1. REGγ expression status was scored according to description in Method & Materials. Overexpression rate of REGγ in each cancer was calculated based on the number of cases scored ++ and above. - v.s + represents two sample weighted student t-test for unequal variance between - group and + group. For - v.s ++/+++, it's between - group and ++/+++ group